|

Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

RECRUITINGSponsored by HealthPartners Institute
Actively Recruiting
SponsorHealthPartners Institute
Started2021-03-19
Est. completion2027-01
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07107607

Summary

The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat their cancer.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* diagnosed with cancer
* have used any type of cannabis/marijuana, including those with cannabidiol (CBD) and/or tetrahydrocannabinol (THC) to treat their cancer
* believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker

Exclusion Criteria:

* does not have cancer
* has not used any type of cannabis/marijuana, including those with CBD and/or THC to treat their cancer
* does not believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker

Conditions2

CancerCancer (With or Without Metastasis)

Locations1 site

HealthPartners Institute Cancer Research Center
Saint Louis Park, Minnesota, 55426
Jordan Cowger, MPH952-993-6071jordan.cowger@parknicollet.com

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.